A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)
Clinical trial NCT07013487 · RECRUITING
Trial details
- NCT number
- NCT07013487
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-11
- Primary completion
- 2031-10-24
- Enrollment
- 12000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.